Form 4: Axon Director Sells Shares in Pre-Planned Trade

Axon Enterprise Director Caitlin Kalinowski sold 580 shares of common stock for approximately $505,000 through pre-arranged trading plans.

Summary

• Director Caitlin Elizabeth Kalinowski of Axon Enterprise, Inc. (AXON) sold a total of 580 shares of common stock.
• The sales occurred on August 7, 2025, and were executed under a Rule 10b5-1(c) pre-planned trading arrangement.
• The first transaction involved the sale of 476 shares at a weighted average price of $870.7414 per share, totaling approximately $414,472.
• The second transaction involved the sale of 104 shares at a weighted average price of $872.0066 per share, totaling approximately $90,680.
• Following these transactions, Kalinowski beneficially owns 4,695 shares of Axon common stock.

Sentiment

Score: 5

Explanation: Neutral. While insider selling can be seen negatively, the execution under a Rule 10b5-1 plan mitigates concerns that it's based on new, adverse information. It's a routine liquidity event for a director.

Positives

• The transactions were executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to new, non-public information.

Negatives

• A director selling shares, even if pre-planned, can sometimes be perceived negatively by investors as it reduces insider ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may note the reduction in insider ownership, though the pre-planned nature of the sale suggests it is not indicative of a change in company outlook.

Key Dates

Recommendation

The sale by a director, while reducing insider ownership, was executed under a pre-planned Rule 10b5-1(c) arrangement. This suggests the transaction is for personal financial planning rather than a reflection of new, negative company-specific information. The relatively small number of shares sold compared to total outstanding shares and the director's remaining holdings does not warrant a change in investment thesis based solely on this filing.

Keywords

Axon Enterprise, AXON, Insider Trading, Form 4, Director Sale, Caitlin Kalinowski, Stock Sale, Rule 10b5-1